drugset / Trial / NCT05923918
A Study to Evaluate Safety and Efficacy of PBK_M2101
RandomizedParallel-groupSingle-blindDiagnostic
Summary
This clinical trial was prospective, randomized, single-blind, 3-treatment arm, parallel treatment group, and active-controlled. , Multi-center, Phase 3 confirmatory clinical trial.
Timeline
- Start
- 2023-06
- Primary completion
- 2024-05
- Completion
- 2024-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PBK_M2101 | Unknown | — | — |